Edmond De Rothschild Holding S.A. Nu Cana PLC Transaction History
Edmond De Rothschild Holding S.A.
- $5.87 Billion
- Q1 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Nu Cana PLC stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 25,000 shares of NCNA stock, worth $64,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 50,000
50.0%
Holding current value
$64,249
Previous $15,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NCNA
# of Institutions
23Shares Held
11.3MCall Options Held
0Put Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA3.4MShares$8.74 Million0.05% of portfolio
-
Abingworth LLP London, X03.33MShares$8.57 Million0.73% of portfolio
-
Carlyle Group Inc. Washington, DC3.33MShares$8.57 Million0.06% of portfolio
-
Acadian Asset Management LLC Boston, MA591KShares$1.52 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny421KShares$1.08 Million0.0% of portfolio
About NuCana plc
- Ticker NCNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,196,000
- Market Cap $134M
- Description
- NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...